Biotec Pharmacon presenting re-established platform at BIO-Europe

Dr Sven Rohmann will present on behalf of Biotec Pharmacon at BIO-Europe Spring
2010 in Barcelona. The presentation will take place at March 9, 12:30, under the
AutoImmune/Inflammation Section.
Biotec Pharmacon is re-establishing the platform for pharmaceutical development
of Soluble Beta Glucan (SBG),  providing the first first evidence  explaining the
outcome of 3 clinical phase III studies.

This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)

[HUG#1391807]

Presentation at BIO-Europe_2010: http://hugin.info/136141/R/1391807/349553.pdf

Wertpapiere des Artikels:
NO0010014632

Bewerten Sie diesen Artikel: (

0

Bewertungen)